Dishearteningly disappointing.
Contact Us Now

For a free, confidential
assessment

Trilipix Drug Injury & Side Effects Lawsuit

Research shows the anti-cholesterol drug choline fenofibrate—sold under the brand names Trilipix and Tricor—does not reduce the risk of heart attacks and strokes in those with type 2 diabetes. The Rottenstein Law Group, a Trilipix law firm, compassionately advocates for those who have suffered Trilipix side effects. If you’ve taken Trilipix believing it would reduce heart-related problems and suffered one nonetheless, contact RLG for a free, confidential legal consultation immediately. We will evaluate your case and remain on the lookout for Trilipix recalls and Trilipix class action lawsuits.

What Is Trilipix and What Is It Prescribed For?

Trilipix is the brand name for the drug choline fenofibrate. Made and sold by American pharmaceutical company Abbott Laboratories, Inc., this prescription medication is used to treat people with dyslipidemia (abnormal levels of cholesterol) and coronary heart disease, severe hypertriglyceridemia (high amounts of fat molecules), and primary hyperlipidemia (high cholesterol) or mixed dyslipidemia. First approved by the U.S. Food and Drug Administration (FDA) in December 2008, Trilipix is often prescribed alongside Zocor (simvastatin). It comes in 45 mg and 135 mg delayed release oral capsules that users take daily.

Trilipix belongs to a class of drugs called “fibrates.” It breaks down low-density lipids (LDLs) and very low-density lipids (VLDLs), which are the cholesterol molecules that can accumulate in people’s arteries and cause heart attacks, and it reduces high levels of fat molecules called “triglycerides.” Trilipix also increases the presence of high-density lipids (HDLs) in people’s bodies.

Trilipix Might Not Reduce Heart-Related Side Effects

On November 9, 2011, the FDA issued a Trilipix warning in the form of a Drug Safety Communication advising the public that the drug might not actually lower diabetics’ risk of suffering heart attacks or strokes. The evidence for this conclusion comes from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial.

The ACCORD Lipid trial used two groups taking simvastatin, 2,765 also received Trilipix and 2,753 received a placebo. The researchers found a statistically insignificant decrease (eight percent) in the incidence of heart attacks and strokes in the Trilipix group compared to the placebo participants.

On May 19, 2011, the FDA Endocrinologic and Metabolic Drugs Advisory Committee met and discussed the results. Months later, the Trilipix drug label included a new heart-related subsection in the “Warnings and Precautions” section. The FDA issued the Drug Safety Communication, which advises those taking the drug to consult with their physician before discontinuing. The FDA is also requiring Abbott Laboratories to conduct clinical trials to test whether the Trilipix and statins are more effective than merely taking a statin.

Trilipix Might Cause Other Side Effects

  • Skeletal muscle side effects, including Rh­abdomyolysis (a disease characterized by severe atrophy of skeletal muscle tissue);
  • Elevated levels of serum creatinine and serum transaminase (liver and kidney problems);
  • Cholelithiasis (gallstones);
  • Bleeding, when combined with oral anticoagulants;
  • Pancreatitis;
  • Skin rashes, including Stevens-Johnson syndrome;
  • Decreases in hemoglobin, hematocrit, and white blood cell counts; and
  • Venothromboembolic disease (blood clots in veins).

RLG’s Trilipix Lawyers Will Make Things Easier

The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The Trilipix lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Trilipix lawsuit on your behalf if necessary. RLG will also keep you up to date on any Trilipix class action lawsuits, FDA Trilipix warnings, and Trilipix FDA recall announcements. If you have taken Trilipix and believe it harmed you, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.

*

  


eight + 7 =

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.